Curling 123: With TP53 showed 17p deletion in... - CLL Support

CLL Support

23,139 members39,744 posts

Curling 123

Curling123 profile image
5 Replies

With TP53 showed 17p deletion in 14.5% of nuclei, 13q in 31% of nuclei, 11q deletion in 13.5% of nuclei. I don’t have any symptoms. With these results, will CLL doc push me to have treatment without symptoms? Leukocytes were at 3.2L. Want to be prepared for appointment with specialist and want to watch/wait. Anybody not have treatment right away with these results?

Written by
Curling123 profile image
Curling123
To view profiles and participate in discussions please or .
5 Replies
Cllcanada profile image
CllcanadaTop Poster CURE Hero

Highly unlike to treat with that low count... they will wait for the CLL to progress...

Those markers are simply an indication of the type of CLL you have, they never treat the numbers.

~chris 🇨🇦

AussieNeil profile image
AussieNeilPartnerAdministrator

It's important to appreciate that these prognostic factors are only some of the better recognised ones. How they interact together and with other more experimental prognostic factors you don't know, is still a developing science. This is all only just statistically relevant for populations with these prognostic markers, not individuals. There is considerable overlap between the different risk populations, which means that it is still the case currently, that the best course is to monitor us for our CLL tempo and only treat when symptoms indicate that that time has come.

Neil

Curling123 profile image
Curling123

Thanks Chris and Neil. You have been a heap of support this past week after diagnosis. I have learned so much on this site. Even my doctor (GP) didn’t have a clue what these numbers meant. Hail to you both.

Jm954 profile image
Jm954Administrator

The advice is to watch and wait until treatment is required but your genetics means that you have high risk CLL and will almost certainly need treatment at some point.

There are a few early clinical trials with a targeted therapy treating high risk CLL patients who do not yet meet the criteria for treatment.

You don't say which country you are in but this paper describes a trial in Ohio, USA

bloodjournal.org/content/13...

and I think there is one in the planning stage in UK too.

Jackie

Curling123 profile image
Curling123

Thank you JM. I am in Canada, Toronto.

Not what you're looking for?

You may also like...

Curling 123

Imbruvica appears to be the preferred therapy from reading these posts. As a senior and in Ontario,...

Curling 123

Anyone from Ontario know if OHIP now covers Imbruvica? What I have found out about it is dated 2014...

New to Forum

I have CLL with TP53 deletion and 11q deletion. I am scheduled for ibrutinib for treatment . I...

NICE Recommends Acalabrutinib for treating CLL for certain groups

NICE has approved Acalabrutinib as monotherapy and is recommended as an option for untreated...

Some answers back from doctor.

Flow cytometry did confirm CLL type cells in blood, FISH studies showed 13q deletion, IGHV status...